EmaxHealth Health News
Home » General Health » Drug Clinical Trials

Making Antibiotics From Alligator Blood

Ads by Google

All About:
  • Drug Clinical Trials

By Armen Hareyan on April 11, 2008 - 12:21pm for eMaxHealth

Researchers are on their way of developing new antibiotics from alligator blood that can even beat even drug-resistant superbugs.

Most of pharmaceutical companies have stopped developing new antibiotics, because the sphere is not that profitable. However, recent mass infections of drug-resistant methicillin-resistant Staphylococcus aureus (MRSA) urge the importance of new antibiotics. This is why a team of scientists from McNeese State University and Louisiana State University started a laboratory test for a new drug.

It is known that alligators can strongly fight infections from bacteria and viruses thanks to blood's defending ability. White cells in alligator blood are the key part of immune system, just as human white cells. Researchers took white cell proteins called peptides as a base for the new antibiotic.

The proteins were exposed to different bacteria in laboratory and it showed to be resistant to most of these killing bacteria. A very small amount of proteins were able to kill MRSA, 6 out of 8 strains of fungus named Candida albicans, and also other bacteria that can kill people with weakened immune system.

Researchers are now looking for ways on how to use alligator proteins in humans, because human body is recognises proteins as foreign elements and rejects them. Researchers will try to make the chemical version of the protein and 'fool' human body, so that it don't recognise the elements as proteins.

Researchers hope that the new antibiotic will be ready in a decade. Laboratory tests are yet successful, but there is no guarantee that the drug will be useful for humans. However, researchers will do their best to make the new drug which is supposed to be in a cream form and called 'alligacin'.

Source: 
eMaxHealth

eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.

  • Add new comment

Similar Stories

  • Medical Research in 2012 a Risk to the United States
  • Dexpramipexole promising in phase II trial for Lou Gehrig's disease
  • Lilly drug evacetrapib dramatically raises HDL cholesterol in trial
  • Genzyme’s MS Drug Lemtrada Gets Positive Results in Clinical Trial
  • Vorapaxar TRACER study halted after safety review

 Dr. Oz Promotes Magnet Cure
 Skin Care Secrets in Your Kitchen
 3 Gadgets to Make You Look 10 Years Younger
 Catalase is the Culprit for Gray Hair
 Vibration Therapy Helps Chronic Pain
 What If Antidepressants Don't Work
 When Obesity is OK for Some

Health Categories

 EMAXHEALTH HOME
 AFFORDABLE HEALTH INSURANCE
 DIET & WEIGHT LOSS
 FITNESS & EXERCISE
 MEN'S HEALTH
 WOMEN'S HEALTH
 BEAUTY
 ALTERNATIVE MEDICINE
 CANCER TREATMENT
 AGING
 DISEASE and CONDITION
 MENTAL HEALTH
 GENERAL HEALTH
 PERSONAL HEALTH
 GOURMET FOOD & HEALTH
 HEALING & SPIRITUALITY
 MONEY AND HEALTH
 Comment Moderation
  • Health RSS Feeds
  • Privacy Policy
  • Disclaimer
  • About Us
  • Editorial Review Process
  • Advertise
  • Contact
  • Contributors
Copyright eMaxhealth.com 2005-2012. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.